 
        
        
        Search
 
    
     
                 
                 
                 
               
               
              Febuxostat is a new and highly effective non-purine xanthine oxidase selective inhibitor for the treatment of hyperuricemia. Febuxostat is a new and highly effective selective inhibitor of non-purine xanthine oxidase. Xanthine oxidase is a key enzyme that promotes uric acid production. Febuxostat can reduce the level of uric acid in the blood of people with hyperuricemia gout.
| Items | Specifications | Results | 
| Appearance | Off-white to white crystalline powder | Off-white crystalline powder | 
| Water | ≤2.0% | 0.12% | 
| Residue on ignition | ≤0.1% | 0.08% | 
| Assay | 98.0%~102.0% | 99.3% | 
| Product parameters | |
| Cas number: | 144060-53-7 | 
| Appearance: | Off-white to white crystalline powder | 
| Purity: | 98~102% | 
| Package details: | 1kg/foil bag; 25kg/drum | 
| Brand: | Fortunachem | 

Febuxostat is primarily indicated in conditions like Gout, Hyperuricemia.

 
      Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
 
        
      Quick Links
Add:
E-mail:
 English
English                   Español
Español                   français
français                   العربية
العربية                   
                                                                                                                                             
                                                                                                                                             
                                                                                                                                                                                       
                                                                                                                                             
                       
                       
                      